pharmaphorum November 22, 2021
Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California’s Institute for Creative Technologies (USC ICT), tells us how its virtual reality (VR) therapy BRAVEMIND is changing PTSD treatment and how pharma can leverage clinical VR.
“There’s a strong evidence base for VR applications in many areas, but it’s also breaking down barriers to care. The value lies in drawing people into treatment, therapy, or wellness and getting them to do things they wouldn’t do in a traditional talk therapy setting,” Skip says.
The World Health Organization estimates 600 million people worldwide have mental health conditions, but only one-third will see the inside of a therapy office.
Implementing clinical VR can improve access and availability...
Today's Sponsors
Today's Sponsor